Abstract GATA-2 deficiency was recently described as common cause of overlapping syndromes of immunodeficiency, lymphedema, familiar myelodysplastic syndrome or acute myeloid leukemia. The aim of our study was to analyze bone marrow and peripheral blood samples of children with myelodysplastic syndrome or aplastic anemia to define prevalence of GATA2 mutation and to assess whether mutation in GATA-2 transcription factor exhibit specific immunophenotypic features. The prevalence of a GATA2 mutation in a consecutively diagnosed cohort of children was 14% in advanced forms of myelodysplastic syndrome (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation and myelodysplasia-related acute myeloid leukemia), 17% in refractory cytopenia of childhood and 0% in aplastic anemia. In GATA-2-deficient cases we found the most profound B cell lymphopenia including its progenitors in blood and bone marrow, which correlated with significantly diminished intronRSS-Kde recombination excision circles in comparison to other myelodysplastic syndrome/aplastic anemia cases. The other typical features of GATA-2 deficiency (monocytopenia and natural killer cell lymphopenia) were less discriminative. In conclusion, we suggest screening for GATA2 mutations in pediatric myelodysplastic syndrome, preferentially in patients with impaired B cell homeostasis in bone marrow and peripheral blood (low number of progenitors, intronRSS-Kde recombination excision circles and naive cells).
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Introduction
Myelodysplastic syndrome (MDS) is a rare disease of childhood with an approximate frequency of 0.8 to 1.8 per million children 1 . The most common subtype of MDS is refractory cytopenia of childhood (RCC), which represents a distinct category that was introduced as a provisional entity in a WHO classification 2008 2 . Aplastic anemia (AA) shares several clinical and laboratory features with RCC, and histopathological assessment is nowadays a key method for the separation of the two diseases 3 .
Advanced MDS in children can be separated into three categories: refractory anemia with excess blasts (RAEB), RAEB in transformation (RAEB-t) or myelodysplasia related acute myeloid leukemia (MDR-AML) 4 . In some children, MDS or hypoplastic bone marrow failure is associated with an underlying genetic predisposition (e.g., Fanconi anemia, dyskeratosis congenita or ShwachmanDiamond syndrome) 5 .
A mutation in the GATA2 gene, which encodes the transcription factor GATA-2, was recently found by whole genome sequencing 6, 7 or by candidate approaches 8, 9 as a common cause of several overlapping syndromes: familial MDS/acute myeloid leukemia (AML); dendritic cell, monocyte, B
and NK lymphoid (DCML) deficiency; mycobacterial infections and monocytopenia (MonoMAC);
and hereditary lymphedema (Emberger syndrome) 6, 7 . Several abnormalities identifiable by flow cytometry (FC) in peripheral blood (PB) are known to be present in patients with GATA2 mutations: a decreased number of B cells, NK cells, monocytes and dendritic cells 10, 11 ; plasma cells with an aberrant immunophenotype in bone marrow (BM); clonal T large granular lymphocyte (LGL) proliferation; and aberrant maturation patterns of granulocytic lineage 10, 12 . MDS manifests in GATA-2-deficient patients earlier than in the general population 11 . A GATA2 mutation in pediatric nonfamilial MDS patients was found in 16% of patients with aberrant karyotype (monosomy 7) 13 .
FC is recognized as an important diagnostic method especially in adult forms of MDS [14] [15] [16] . In children the amount of FC abnormalities in comparison to adults especially in RCC is often limited 17 . Myeloid compartment is severely reduced in both RCC and AA in comparison to healthy controls, but in AA the reduction is more pronounced 18 . All Czech patients with suspected MDS and AA have undergone trephine biopsy analysis by one of two expert pathologists since 2005, and BM aspirates were always analyzed in parallel using FC when material is available. We also analyzed level of intronRSS-Kde recombination excision circles (KRECs) in PB and BM to assess B cell production in children with MDS and AA.
The aims of our study were two-fold. First aim was to define prevalence of GATA2 mutation in nationwide pediatric cohort of MDS/AA patients. Second aim was to identify FC profile characteristic for GATA-2-deficient patients.
Methods
Patients
Patients entered the study after their parents or guardians signed informed consent and the institutional ethics committee approved the study. Patients with RCC and AA were analyzed between 2005 and 2014, and all patients were analyzed histopathologically. Non-RCC (12 RAEB, 5 RAEB-t, 3 MDR-AML) patients were analyzed in period 1998 -2014. Only the patients with available material for screening of GATA2 mutation entered the study (three additional AA patients were analyzed using FC during the study period, but no material was available for GATA2 mutation screening, and neither FC nor GATA2 screening was performed in one RCC patient and no material for GATA2 mutation screening was available in 3 non-RCC patients).
The prevalence of GATA2 mutation was analyzed among Czech pediatric primary MDS/AA patients (RCC (n=30), AA (n=38), non-RCC (n=22)). The flow chart describing cohort of patients is in Online Supplementary Appendix.
We used residual material from grafts for stem cell transplantation and samples taken for infiltration assessments of non-hematopoietic tumors as control BM samples (n=35 The distinction between RCC and AA was based on histopathological criteria and cytogenetic findings (both summarized in Online Supplementary Appendix). Patients with cytogenetic aberration before start of the treatment were classified as RCC regardless of the histopathological picture. Two patients were classified as RCC without histopathological dysplasia: one RCC GATA2 wild type patient with familiar history of MDS had simultaneous monosomy 7 and trisomy 8, and one GATA-2-deficient patient had monosomy 7.
Further details on diagnostics including flow cytometry, cytogenetics and DNA isolation may be found in the Online Supplementary Appendix.
GATA2 sequencing
GATA2 mutation status was investigated in all MDS/AA patients with available material. Genomic DNA was extracted from BM or PB samples. The entire coding region of GATA2 and an intronic enhancer region 3' to exon 6 were amplified using genomic PCR. Further details may be found in the Online Supplementary Appendix.
KREC/TREC detection
Albumin gene level was quantitatively detected in isolated samples using qPCR, and a standard dilution series was derived from human genomic DNA with a known starting concentration (Roche, Basel, Switzerland). The levels of T cell receptor excision circle (TREC) and KREC signal joints were assessed separately using serial dilutions of cloned plasmid standards as previously described 19 
y)
. The control groups for PB and dried blood spot were included in a previous study 21 .
Statistics
Details may be found in the Online Supplementary Appendix.
Results
Prevalence of GATA-2 deficiency in pediatric MDS/AA
We investigated the prevalence of GATA-2 deficiency in samples taken from Czech pediatric patients under 18 years of age who developed MDS or AA. Eight of 90 pediatric MDS/AA patients had a GATA2 mutation. Three of these patients were diagnosed with non-RCC and 5 patients were diagnosed with RCC (Supplementary figure 1) . The prevalence of a GATA2 mutation was 17%, 14%
and 0% within RCC, non-RCC, and AA groups, respectively. The prevalence of a GATA2 mutation in patients with cytogenetic aberrations was 41% and 17% in patients with monosomy 7 and trisomy 8, respectively.
Bone marrow histology of GATA-2 deficient patients GATA-2-deficient RCC patients did not differ in histopathology from other RCC patients, similarly no difference between GATA2 mutated patients with advanced MDS in comparison to other advanced patients was observed. All bone marrow samples from RCC patients including GATA-2-deficient in our study were hypocellular. There was only one patient (UPN3 with Emberger syndrome) within GATA-2-deficient group with higher degree of fibrosis (MF-2).
B cell compartment composition and production of B cells exhibit distinct features, especially in GATA-2-deficient patients
The proportion of B cells in BM in our control group inversely correlated with age ( Supplementary   Figure 2) , which is in line with previously published data 23, 24 . The lowest proportion of B cells was present in GATA-2-deficient patients ( Figure 1 , Table 3 ). The highest proportion of B cells was present in the AA group, which may be explained by a severe reduction in the myeloid compartment Table 3 ).
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B cell subsets were analyzed in PB using the lineage-defining marker CD19 in combination with Figure 3A) . A decreased percentage of PB B cells was present in 10 of 12 patients ( Figure 3A) . A normal percentage of B cells was observed in one RCC patient (UPN3), and one value out of three was below the normal range in another RCC patient (UPN6; Figure 3A ). Table 3 ). Very low levels of KRECs together with a decrease in B cell progenitors and proportional increase in plasma cells in BM indicate a defect in B cell production in GATA-2-deficient patients. We identified three RCC patients with almost no KRECs in BM and PB and no GATA2 mutation (Figures 1 and 2 ).
Notably, one of these patients had a family history of MDS; her mother underwent SCT for MDS RAEB. We also analyzed available newborn blood spots (Guthrie cards), which were used for the neonatal screening of metabolic disorders, from four GATA-2-deficient patients. We observed normal KREC levels at birth in three patients (UPN1, UPN6, UPN8), but there were no KRECs at birth in another patient (UPN11) who exhibited the earliest MDS RAEB manifestation in our GATA-2-deficient cohort ( Figure 2 , Table 2 ).
Patient UPN9 with a GATA2 intronic mutation progressed rapidly to AML within three months after (Table 3) .
We observed an increased percentage of T cells also in PB in GATA-2-deficient patients.
The progenitor compartment is severely reduced in AA deficiency) compared with controls. However, neither CD34 nor CD117 alone can be used for the diagnostic discrimination between RCC and AA because of the substantial overlap.
Myeloid populations and NK cells in GATA-2 deficiency
Unexpectedly, the analysis of BM monocytes revealed that the only group different from controls was AA presenting with BM monocytopenia ( Figure 1 , Table 3 ). In PB, monocytopenia is often regarded as one of the hallmark of GATA-2 deficiency 10 . Although we did observe absolute monocytopenia at least in some specimens of 10 of 11 GATA-2 deficient patients, majority of the patients show The granulocytic compartment in BM generally contains neutrophils; eosinophils and basophils are only minor subpopulations in normal BM. We focused on the evaluation of the total percentage of granulocytes in BM. The percentage of granulocytes in GATA-2-deficient patients did not differ from controls (Table 3 ), but we frequently found aberrancies in maturation as detected by CD16 and CD13 expression in this group. We observed a complete absence of CD16 on all forms of granulocytes in one of six patients with GATA-2 deficiency analyzed. We observed a disturbed maturation profile with an accumulation of CD16 . Non-RCC and AA patients presented with fewer granulocytes than the remaining cohorts, including controls (Table 3 ). In PB, neutropenia was frequently present in GATA-2-deficient patients ( Figure 3B ), and at least some of the absolute neutrophil count (ANC) values were below 1x10 9 /L in all but one patient (UPN7).
NK lymphopenia was present in half of the GATA-2-deficient cases ( Figure 3B ).
B lymphopenia is more specific and sensitive parameter for discriminating pediatric patients with GATA-2 deficiency
To determine which parameters are the best for identifying GATA-2-deficient patients among patients with MDS and AA, we performed ROC curves analysis comparing peripheral blood monocytes, B cells and natural killer (NK) cells (absolute and relative counts). Higher sensitivity and specificity can be reached using either relative or absolute counts of B cells compared to both monocytes and NK cells ( Figure 4 ). Lower-than-physiological counts of B cells were found in 10 of 12 GATA-2-deficient patients ( Figure 3A ), and decreased KREC levels were found in all GATA-2-deficient patients ( Figure   1A and 2A).
Discussion
Mutations in the transcription factor GATA-2 leading to haploinsufficiency is a frequent germline genetic aberration found in pediatric MDS. We compared flow cytometry results, KREC and TREC levels in pediatric patients with MDS and AA to pediatric control samples with focus on GATA2 The other features known to be associated with GATA-2 deficiency, i.e. monocytopenia and NK lymphopenia were less discriminative in our cohort. The most profound BM monocytopenia in the AA group contrasts a recently published study by Ganapathi et al. 10 , who found the lowest amount of monocytes in GATA-2-deficient MDS patients, lower than AA. In our GATA-2-deficient cohort, the most profound monocytopenia in BM and PB was found in two patients with immunodeficiency and severe lung problems. Two patients with advanced form of MDS presented with monocytosis in BM.
This result is consistent with previous observations that GATA-2-deficient patients whose disease Relative T cell counts were increased in GATA-2-deficient patients in PB and BM. Low levels of
TRECs in GATA-2 may be explained by the decreased production and/or by expansion of mature T cells during infections. In contrast to previously published GATA-2-deficient cohorts, we did not observe an expansion of T large granular lymphocytes in BM in any of our patients. T cell deficiency, namely CD4 lymphopenia contributes to immunodeficiency in GATA2-mutated patients 28 . We observed CD4 lymphopenia below 0.4.10^9/L in 3 patients, 2 of them were followed for severe lung disease.
We assessed the prevalence of GATA-2 deficiency in Czech children with MDS or AA. A GATA2 mutation was exclusively identified in patients with RCC (17%) or advanced MDS (non-RCC; 14%).
AA and RCC generally exhibit similar clinical and laboratory features. Some of the flow cytometric differences between RCC and AA that we observed in the past were driven by the GATA-2-deficient group (namely B cell lymphopenia) 31, 32 . Differences between the overlapping categories RCC and AA are frequently discussed, especially in patients with hypocellular BM and without adverse cytogenetics. The separation of patients into two categories seems to be less relevant because immunosuppressive therapy is indicated for both disease groups [33] [34] [35] , and there is no difference in prognosis nor in probability of progression into advanced MDS 35 . We observed significant differences In summary, we found that the disturbances in the B cell compartment were the strongest distinguishing biological feature of GATA-2 deficiency in childhood MDS, in contrast to other recently published factors, such as monocytopenia, which were less common and unspecific in our study. The finding of decreased B cell numbers in BM and PB, and most specifically, low levels of B cell progenitors in BM together with very low or absent KRECs in BM and PB can identify 1 0 appropriate candidates for GATA2 mutation testing in pediatric MDS patients. Information on mutational status in the family is of importance not only when matched family donor is considered for the transplantation. GATA-2 deficiency does not only predispose to cancer but also an immunodeficient condition in which close immunological monitoring with careful treatment of infections might prevent organ damage as we observed in UPN7.
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